Tobler DL, Pruzansky AJ, Naderi S, Ambrosy AP, Slade JJ (2022) Long-term cardiovascular effects of COVID-19: emerging data relevant to the cardiovascular clinician. Curr Atheroscler Rep 24:563–570
Izquierdo-Marquisá A, Cubero-Gallego H, Aparisi Á, Vaquerizo B, Ribas-Barquet N (2022) Myocardial injury in COVID-19 and its implications in short- and long-term outcomes. Front Cardiovasc Med 9:901245
Babapoor-Farrokhran S, Gill D, Walker J, Rasekhi RT, Bozorgnia B, Amanullah A (2020) Myocardial injury and COVID-19: Possible mechanisms. Life Sci 253:117723
Metkus TS, Sokoll LJ, Barth AS, Czarny MJ, Hays AG, Lowenstein CJ, Michos ED, Nolley EP, Post WS, Resar JR, Thiemann DR, Trost JC, Hasan RK (2021) Myocardial injury in severe COVID-19 compared with non-COVID-19 acute respiratory distress syndrome. Circulation 143:553–565
Zuin M, Rigatelli G, Zuliani G, Bilato C, Zonzin P, Roncon L (2020) Incidence and mortality risk in coronavirus disease 2019 patients complicated by acute cardiac injury: systematic review and meta-analysis. J Cardiovasc Med (Hagerstown) 21:759–764
Moher D, Liberati A, Tetzlaff J, Altman DG, PRISMA Group (2009) Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. PLoS Med 6:e1000097
Wells GA, Shea B, O’Connell D, Peterson J, Welch V, Losos M, Tugwell P (2012) The Newcastle-Ottawa Scale (NOS) for assessing the quality if nonrandomized studies in meta-analyses. https://www.ohri.ca/programs/clinical_epidemiology/oxford.asp. Accessed 29 Aug 2022
Cohen K, Ren S, Heath K, Dasmariñas MC, Jubilo KG, Guo Y, Lipsitch M, Daugherty SE (2022) Risk of persistent and new clinical sequelae among adults aged 65 years and older during the post-acute phase of SARS-CoV-2 infection: retrospective cohort study. BMJ 376:e068414
Wang W, Wang CY, Wang SI, Wei JC (2022) Long-term cardiovascular outcomes in COVID-19 survivors among non-vaccinated population: a retrospective cohort study from the TriNetX US collaborative networks. EClinicalMedicine 53:101619
Xie Y, Xu E, Bowe B, Al-Aly Z (2022) Long-term cardiovascular outcomes of COVID-19. Nat Med 28:583–590
Salah HM, Fudim M, O’Neil ST, Manna A, Chute CG, Caughey MC (2022) Post-recovery COVID-19 and incident heart failure in the National COVID Cohort Collaborative (N3C) study. Nat Commun 13:4117
Daugherty SE, Guo Y, Heath K, Dasmariñas MC, Jubilo KG, Samranvedhya J, Lipsitch M, Cohen K (2021) Risk of clinical sequelae after the acute phase of SARS-CoV-2 infection: retrospective cohort study. BMJ 373:n1098
Lacny S, Wilson T, Clement F, Roberts DJ, Faris P, Ghali WA, Marshall DA (2018) Kaplan-Meier survival analysis overestimates cumulative incidence of health-related events in competing risk settings: a meta-analysis. J Clin Epidemiol 93:25–35
Nishiga M, Wang DW, Han Y, Lewis DB, Wu JC (2020) COVID-19 and cardiovascular disease: from basic mechanisms to clinical perspectives. Nat Rev Cardiol 17:543–558
Carfì A, Bernabei R, Landi F (2020) Persistent symptoms in patients after acute COVID-19. JAMA 324:603–605
Bader F, Manla Y, Atallah B, Starling RC (2021) Heart failure and COVID-19. Heart Fail Rev 26:1–10
Cowie MR, Mourilhe-Rocha R, Chang HY, Volterrani M, Ban HN, Campos de Albuquerque D, Chung E, Fonseca C, Lopatin Y, Magaña Serrano JA, Mircheva L, Moncada-Paz GA, Pagava Z, Reyes EB, Saldarriaga C, Schwartzmann P, Sim Kheng Leng D, Trivi M, Yotov YT, Zieroth S, Heart Failure Care OPTIMIZE, program coordinators (2022) The impact of the COVID-19 pandemic on heart failure management: Global experience of the OPTIMIZE Heart Failure Care network. Int J Cardiol 363:240–246
Zhang HG, Dagliati A, Shakeri Hossein Abad Z, Xiong X, Bonzel CL, Xia Z, Tan BWQ, Avillach P, Brat GA, Hong C, Morris M, Visweswaran S, Patel LP, Gutiérrez-Sacristán A, Hanauer DA, Holmes JH, Samayamuthu MJ, Bourgeois FT, L’Yi S, Maidlow SE, Moal B, Murphy SN, Strasser ZH, Neuraz A, Ngiam KY, Loh NHW, Omenn GS, Prunotto A, Dalvin LA, Klann JG, Schubert P, Vidorreta FJS, Benoit V, Verdy G, Kavuluru R, Estiri H, Luo Y, Malovini A, Tibollo V, Bellazzi R, Cho K, Ho YL, Tan ALM, Tan BWL, Gehlenborg N, Lozano-Zahonero S, Jouhet V, Chiovato L, Aronow BJ, Toh EMS, Wong WGS, Pizzimenti S, Wagholikar KB, Bucalo M; Consortium for clinical characterization of COVID-19 by EHR (4CE), Cai T, South AM, Kohane IS, Weber GM (2022) International electronic health record-derived post-acute sequelae profiles of COVID-19 patients. NPJ Digit Med 5:81
Sidik SM (2022) Heart disease after COVID: what the data say. Nature 608:26–28
Cozzolino F, Montedori A, Abraha I, Eusebi P, Grisci C, Heymann AJ, Lombardo G, Mengoni A, Orso M, Ambrosio G (2019) A diagnostic accuracy study validating cardiovascular ICD-9-CM codes in healthcare administrative databases. The Umbria Data-Value Project PLoS One 14:e0218919
Delekta J, Hansen SM, AlZuhairi KS, Bork CS, Joensen AM (2018) The validity of the diagnosis of heart failure (I50.0-I50.9) in the Danish National Patient Register. Dan Med J 65:A5470
Greene SJ, Lautsch D, Yang L, Tan XI, Brady JE (2022) Prognostic interplay between COVID-19 and heart failure with reduced ejection fraction. J Card Fail 28:1287–1297
留言 (0)